Check-Cap Ltd. (NASDAQ:CHEK) Short Interest Down 7.3% in May

Check-Cap Ltd. (NASDAQ:CHEKGet Free Report) was the recipient of a large decrease in short interest during the month of May. As of May 31st, there was short interest totalling 191,100 shares, a decrease of 7.3% from the May 15th total of 206,200 shares. Based on an average daily volume of 244,400 shares, the days-to-cover ratio is currently 0.8 days. Approximately 4.4% of the company’s stock are short sold.

Analysts Set New Price Targets

Separately, StockNews.com began coverage on Check-Cap in a research note on Tuesday. They set a “sell” rating for the company.

Read Our Latest Research Report on Check-Cap

Check-Cap Stock Performance

Check-Cap stock traded down $0.05 during midday trading on Tuesday, hitting $2.19. 5,566 shares of the company were exchanged, compared to its average volume of 145,797. The firm has a market capitalization of $12.81 million, a PE ratio of -0.73 and a beta of 0.44. Check-Cap has a fifty-two week low of $1.78 and a fifty-two week high of $4.63. The business has a fifty day simple moving average of $2.24 and a two-hundred day simple moving average of $2.24.

Check-Cap (NASDAQ:CHEKGet Free Report) last issued its quarterly earnings data on Wednesday, May 15th. The medical research company reported ($0.62) EPS for the quarter. As a group, equities analysts expect that Check-Cap will post -0.68 earnings per share for the current year.

Check-Cap Company Profile

(Get Free Report)

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.

Further Reading

Receive News & Ratings for Check-Cap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check-Cap and related companies with MarketBeat.com's FREE daily email newsletter.